Kurser indlæses...

Prognose

Køb	1
Behold	0
Sælg	0

Nyheder Til nyhedsfeedet

BIOkey beats profit target, misses revenue forecast and stock falls sharply

BIOkey reported an adjusted loss of $0.56 per share for Q2/2026, beating expectations, while revenue of $1.92 million missed the consensus of $2.2 million. Gross margins and licensing income rose significantly, and net loss narrowed 51% year over year, but a delayed large order and a warrant financing weighed on the market reaction. The stock fell about 12%; management expects profitability in H2/2026 and sees growth potential in Passkey:YOU, PortalGuard 7.0 and in EMEA/Middle East. » Mere på de.investing.com
BIO key increases revenue by 13%; net loss halved

BIO key reported Q2 revenue of USD 1.9 million (up 13%) and a halved net loss of USD 577,000. License revenues rose 53% to USD 1.2 million, while hardware sales fell 19%; expected hardware sales of about USD 800,000 were pushed into H2 2026. Gross margin improved to 87%; cash balance increased to over USD 4.5 million following the exercise of warrants. The company announced several customer contracts (including Saudi Arabia, Portugal, Jordan) and completed a 1:10 reverse stock split, restoring NASDAQ listing requirements. » Mere på de.investing.com
BIO-key receives reprimand from Nasdaq over late 10-Q filing

BIO-key received a reprimand from Nasdaq for noncompliance with Rule 5250(c)(1) after the quarterly report (Form 10-Q) for the period ended March 31, 2026 was not filed with the SEC on time. The Nasdaq Hearing Panel will take the violation into account when deciding on the company’s continued listing on the Nasdaq Capital Market. The stock has fallen 41% over the past six months and is currently trading at $4.10 with a market capitalization of about $4.45 million; InvestingPro rates the financial position as “WEAK” with a score of 1.67, but sees possible undervaluation. » Mere på de.investing.com

Virksomhedstal

I det seneste kvartal havde BIO-Key International en omsætning på 1,68 mio. € og et nettoresultat på -505,44 t €

(EUR)	juni 2026	YoY
Omsætning	1,68 mio.	16,85 %
Bruttofortjeneste	1,47 mio.	40,25 %
Nettoresultat	-505,44 t	48,97 %
EBITDA	-380,67 t	56,91 %

Fundamentale data

Nøgletal	Værdi
Markedsværdi	3,39 mio. €
Antal aktier	1,44 mio.
Højeste/laveste i 52 uger	12,38 € - 1,39 €
Udbytte	Nej
Beta	0,40
P/E (PE Ratio)	-0,65
PEG (PEG Ratio)	0,00
K/I (PB Ratio)	0,63
P/S (PS Ratio)	0,55

Virksomhedsprofil

BIO-key International, Inc. udvikler og markedsfører fingeraftryksbaseret biometrisk identifikationsteknologi og softwareløsninger samt klar-til-brug identitets- og adgangsstyringsløsninger til kommercielle, offentlige og uddannelsesmæssige kunder i USA og internationalt. Virksomheden tilbyder BIO-key PortalGuard og PortalGuard IDaaS, en kundestyret og neutralt designet cloudbaseret identitetsplatform, der gør det muligt for kunder at integrere med enhver cloud- eller on-premises SaaS-applikation, samt Windows-enhedsgodkendelse via IAM-platformen. Dens løsninger gør det muligt for kunderne at sikre deres medarbejdere og studerendepopulationer og gøre deres partnernetværk mere samarbejdsorienterede. Derudover tilbyder den BIO-key VST- og WEB-key-produkter samt løsninger til civil og storskala ID-infrastruktur, som udvikler fingerbaseret biometrisk teknologi. Desuden tilbyder den fingerscannere til virksomheds- og forbrugermarkedet under mærkenavnene SideSwipe, EcoID og SidePass. Virksomheden var tidligere kendt som SAC Technologies og ændrede sit navn til BIO-key International, Inc. i 2002. BIO-key International, Inc. blev grundlagt i 1993 og har hovedkontor i Wall, New Jersey.